Here’s the situation:
You want to find high-potential stocks.
But you don’t know where to start.
Should you focus on stocks with excellent quant ratings? Or, should you focus on stocks with excellent analyst sentiment?
Why not both?
The more checks and balances you have on a potential investment, the more conviction you can build.
WallStreetZen’s new Zen Ratings + Top Analysts screener gives you both: Stocks that have above-average scores according to our 115-factor Zen Ratings system — and also have recent Strong Buy ratings from top-rated analysts.
Want to give it a test drive? Here are the top 2 stocks from the aforementioned screener.
Both of them have a Zen Rating of A and a Strong Buy analyst consensus from the analysts we follow:
A note from our sponsors...
The Best 10 AI Stocks to Own in 2025 Discover the AI pioneer 99% of investors have never heard of... but it's one of my top picks to own now. This company has been an AI pioneer since before anyone ever heard of ChatGPT. Its sustained high double-digit growth has analysts raising price targets. Get the name-FREE. Discover this under-the-radar AI stock now, ahead of the crowd.
True: The biotech industry isn’t exactly known for its stability. But this stock stands out.
Biomarin specializes in therapies for people with rare conditions and diseases. It has a promising future with some therapies potentially leading to a bright future for patients — and potentially stakeholders and shareholders.
It also recently acquired Inozyme Pharma to increase its reach in the field of enzyme therapies (among other fields), pending finalization.
On the analyst side of things, BMRN has an analyst consensus of Strong Buy and the price forecast for the next 12 months is +21.78% at a minimum. See the ratings here
Our Zen Ratings system agrees with its component grades, with BMRN receiving a Component Grade of A for Value. It also receives a Component Grade of B for Sentiment, Financials, and Artificial Intelligence (our algorithms have detected trends in the stock that indicate future superior stock price results). In short, these ratings indicate that BMRN exhibits strong signs of financial health and is not reliant on debt, and that analyst and investor opinions of the stock are positive.
The software company specializing in payments and monetary software is our second selection for your consideration today, with the company recently releasing Connectic (a payments platform) and receiving positive buzz despite a recent share price downturn over the past few months.
Reviewing the Zen Rating, ACIW receives an A Component Grade for Sentiment, indicating it scores well on metrics related to insider action, short interest, analysts' recommendations, and other factors. It does have strong Financials and Artificial Intelligence Component Grades of B, as well, indicating a stable foundation for the company and signs that may signify positive trends for the stock in the future.
The consensus of the analysts we cover who cover the stock is a strong buy, although note that there are only two making that consensus (not as many as most stocks), and you will want to perform further research yourself. They do hold a positive forecast of +26.64% over the next 12 months, however.
Want to learn more about the above stocks, stocks like them, or be able to keep track of other stocks you’re interested in? Then WallStreetZen Premium is your best option. With it, you’ll have an unlimited watchlist, access to premium stock ideas pages (including our Zen Ratings & Top Analysts page), and all the fundamental information you’ll need to improve your portfolio.
If you want more guidance, Zen Investor is right for you. With it, our own Steve Reitmeister provides guided stock picks, recommendations, and insights into the current market. With his more than 40 years of investing experience, you’ll be able to feel more confident in your decisions.
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.